No Data
Fushine Pharma Completes Establishment of Subsidiary
Jiangxi Fushine Pharmaceutical (300497.SZ) established a wholly-owned subsidiary Jiangxi Fushine (Fuyu) Technology.
Jiangxi Fushine Pharmaceutical (300497.SZ) announced that the company has established Jiangxi Fushine (Wealthy) Biotechnology Co., Ltd. with its own funds...
Jiangxi Fushine Pharmaceutical (300497.SZ) specific Shareholder Yu Wenjun has completed a Shareholding reduction of 4.4054 million shares.
Jiangxi Fushine Pharmaceutical (300497.SZ) announced that a specific Shareholder, Yu Wenjun, from December 9 to 20, 2024...
Even After Rising 9.6% This Past Week, Jiangxi Fushine Pharmaceutical (SZSE:300497) Shareholders Are Still Down 34% Over the Past Three Years
Fuxiang Pharmaceutical: 2024 Annual Results Forecast
Some Jiangxi Fushine Pharmaceutical Co., Ltd. (SZSE:300497) Shareholders Look For Exit As Shares Take 26% Pounding
The Market Doesn't Like What It Sees From Jiangxi Fushine Pharmaceutical Co., Ltd.'s (SZSE:300497) Revenues Yet
